Investors registered heartfelt support for this biotechnology company.
News & Analysis: Abiomed
The company is weathering a coronavirus-related shutdown, and a new purchase will help with diversification.
Investors were encouraged by the company's Q4 earnings beat.
ABMD earnings call for the period ending March 31, 2020.
Also, the company's products could help keep COVID-19 patients alive.
ABMD earnings call for the period ending December 31, 2019.
The medical device maker's stock dropped 9%, then recovered.
Abiomed had a rough time in 2019, but the growth story hasn’t changed. Recent share declines could be an opportunity to make a great entry point.
Abiomed's sneak peek at its Q3 results leaves investors underwhelmed.
Which biotech was a 37-bagger?